QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and is leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required quality and safety standards and maintain a leading FDA compliance record, so hospitals can more confidently and reliably focus on patient care. While our leading cGMP processes, sterile-to-sterile portfolio, and expansive capacity of 300,000 sq ft across four facilities are the foundation of success, it is our transparency, customer-focused service, and contracted supply arrangements that enable us to help hospitals and health systems better meet their patient care and operational needs.
As FDA compliance becomes more stringent, QuVa's ability to reliably supply the highest-quality products is more valuable than ever and allows hospitals to spend more time on patient care and less time worried about beyond use dates, waste, workload inefficiencies, and compliance. That is why QuVa is proud to be recognized as the partner of choice for many of the nation’s leading health systems. So, whether you are calling for a response or being called on for a solution, know that QuVa is accountable, and in us, you always have an answer.
As FDA compliance becomes more stringent, QuVa's ability to reliably supply the highest-quality products is more valuable than ever and allows hospitals to spend more time on patient care and less time worried about beyond use dates, waste, workload inefficiencies, and compliance. That is why QuVa is proud to be recognized as the partner of choice for many of the nation’s leading health systems. So, whether you are calling for a response or being called on for a solution, know that QuVa is accountable, and in us, you always have an answer.
Location: United States, Texas, Sugar Land
Employees: 501-1000
Total raised: $356M
Founded date: 2015
Investors 1
Date | Name | Website |
- | Bain Capit... | baincapita... |
Funding Rounds 3
Date | Series | Amount | Investors |
06.05.2021 | - | $275M | - |
25.07.2018 | - | $41M | - |
31.01.2018 | - | $40M | - |
Mentions in press and media 16
Date | Title | Description |
20.06.2024 | $1M donation to Rice establishes pioneering neuro-policy center in Houston | A big donation to Rice University will soon help researchers better understand the workings of the human brain. Harry Yan and Weiman Gao have bestowed $1 million on the Baker Institute of Public Policy to establish the interdisciplinary Neu... |
20.06.2024 | Houston HR software startup rolls out platform at local hospital system | More than 14,000 nurses at one of the largest nonprofit health care providers in Texas have access to a new skills and competency management software. Kahuna Workforce Solutions has officially deployed its platform at Memorial Hermann Healt... |
17.06.2024 | 8 Houston entrepreneurs recognized on annual EY awards program | Eight Houston-area entrepreneurs have been named regional winners in Ernst & Young’s 2024 Entrepreneur Of The Year program. The eight entrepreneurs are among 16 recipients of EOY’s Gulf South Award, which recognizes leaders of high-grow... |
17.06.2024 | Houston Airports to explore autonomous, fully electric air taxis in Houston region | A fleet of electric and autonomous air taxis is expected to take flight in Houston, thanks to a partnership between a California startup and the Houston Airport System. HAS announced a Memorandum of Understanding with Wisk Aero, a fully-own... |
13.02.2024 | QuVa Pharma, Inc. - 675685 - 01/26/2024 | Delivery Method: Via Electronic Mail - Delivery and Read Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Stuart Hinchen QuVa Pharma, Inc. 3 Sugar Creek Center Blvd, Suite 250 Sugar Land, TX 77478 United States stuart.hinchen@... |
26.10.2021 | The $100M+ Dollar Club of U.S. Startups: Texas | Located in the south-central part of the country, Texas is the second-largest state in the US, extending nearly 1,600 km from north to south and around the same distance from east to west. The state is known for its great agricultural wealt... |
06.05.2021 | QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs | |
28.10.2020 | QuVa Pharma Expands Its Partnership With Kit Check™ to Help Hospitals Improve Medication Management and Automation Through RFID Tagging | |
25.07.2018 | QuVa Pharma Raises Up To $41M Debt Funding | QuVa Pharma, a Sugar Land, Texas-based provider of compounded sterile products, raised additional debt funding of up to $41m. The new term loan is funded jointly by Silicon Valley Bank and Oxford Finance LLC. This additional capital infusio... |
25.07.2018 | Oxford Finance Leads $41M Debt Funding For QuVa Pharma | QuVa Pharma, Inc. today announced it has raised additional debt funding of up to $41 million to support business growth initiatives impacting 2019. The new Term Loan is funded jointly by Silicon Valley Bank and Oxford Finance LLC. With this... |
Show more